SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 21.51 |
| Enterprise Value ($M) | 52.41 |
| Book Value ($M) | -101.42 |
| Book Value / Share | -2.83 |
| Price / Book | -0.21 |
| NCAV ($M) | -113.56 |
| NCAV / Share | -3.16 |
| Price / NCAV | -0.19 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -2.33 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.30 |
| Current Ratio | 0.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 19.07 |
| Assets | 31.21 |
| Liabilities | 132.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -67.14 |
| Net Income | -124.11 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -48.50 |
| Cash from Investing | 2.44 |
| Cash from Financing | 30.78 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Athyrium Opportunities 2020 LP | 49.90 | 19.07 | |
| 13G/A | Armistice Capital, Llc | 3.80 | -91.72 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,852 | 102,344 | 29.17 | |
| 135,401 | 94,763 | 142.88 | |
| 50,553 | 317,789 | 15.91 | |
| 101,003 | 244,168 | 41.37 | |
| 145,203 | 452,759 | 32.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVTE – Aerovate Therapeutics, Inc. | AXSM – Axsome Therapeutics, Inc. |
| BCAB – BioAtla, Inc. | BTMD – biote Corp. |
| CADL – Candel Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io